Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops and sells pharmaceuticals and medical devices

Photocure ASA engages as a pharmaceutical company, which engages in the provision of photodynamic diagnosis and treatment.

It operates through Commercial Franchise and Development Portfolio segments.

The Commercial Franchise segment includes Hexvix/Cysview products and is broken down into own and partner sales.

The Development Portfolio segment offers development of commercial products and pipeline
products.

The company was founded on August 27, 1993 and is headquartered in Oslo, Norway.

Number of employees : 49 persons.
Sales per Businesses
20142015Delta
NOK (in Million)%NOK (in Million)%
Cancer92.0171.4%---
Dermatology1.571.2%---
Commercial Franchise--134.72100%-
Sales per Regions
20142015Delta
NOK (in Million)%NOK (in Million)%
Partner Countries Europe47.8937.1%60.6545% +26.63%
Nordic Countries33.4225.9%38.6728.7% +15.72%
United States12.289.5%23.0217.1% +87.47%
Managers
NameAgeSinceTitle
Kjetil Hestdal MD, PhD571997President, Chief Executive Officer & Media Contact
Bente-Lill B. Romøren682014Chairman
Erik Dahl-2012Chief Financial Officer & IR Contact
Inger Ferner Heglund622006Vice President-Research & Development
Xavier Denis Yon772011Independent Director
Synne Hermansen Røine, MBA382014Independent Director
Tom Edward Pike57-Independent Director
Lars Rønn53-Independent Director
Grete Hogstad612005Vice President-Strategic Marketing
Gry Stensrud, PhD472006VP-Technical Development & Operations
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 21,545,429 15,878,472 73.7% 809 0.0% 73.7%
Shareholders
NameEquities%
Alexander Brask Hansson 3,230,000 15.0%
KLP Kapitalforvaltning AS 1,406,622 6.53%
Fondsfinans Kapitalforvaltning ASA 1,181,000 5.48%
Hunter Hall Investment Management Ltd. 859,976 3.99%
Danske Capital AS 859,851 3.99%
Skagen AS 424,123 1.97%
Eika Kapitalforvaltning AS 366,001 1.70%
DNB Asset Management AS 309,889 1.44%
Polar Capital LLP 254,549 1.18%
Kjetil Hestdal, MD, PhD 128,873 0.60%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
PHOTOCURE ASA-4.76%99
JOHNSON & JOHNSON-0.53%311 773
ROCHE HOLDING LTD.2.75%204 641
PFIZER INC.0.12%197 343
NOVARTIS AG-1.48%189 749
MERCK & CO., INC.5.89%171 880
SANOFI1.52%107 323
GLAXOSMITHKLINE PLC1.50%94 828
BRISTOL-MYERS SQUIBB C..-3.80%93 957
BAYER AG2.54%89 438
ELI LILLY AND CO5.23%85 446
ALLERGAN PLC2.92%81 070
NOVO NORDISK A/S-1.73%72 097
ASTRAZENECA PLC3.86%70 916
ABBOTT LABORATORIES6.56%70 653
SHIRE PLC-0.48%51 258
TAKEDA PHARMACEUTICAL ..-0.35%33 647
ASTELLAS PHARMA INC-2.09%30 289
MYLAN NV-3.72%19 654
EISAI CO., LTD-2.10%17 174
CHUGAI PHARMACEUTICAL ..2.38%16 861
Sector Pharmaceuticals - NEC
Photocure ASA : Connections
Photocure ASA
Hoffsveien 4
Oslo 0275

Phone : +47.22.06.22.10
Fax : +47.22.06.22.18
Web : www.photocure.com
© 2017 People , Fundamentals and Ownership